Embecta Corp. (EMBC)

Market Cap	814.70M
Revenue (ttm)	1.10B
Net Income (ttm)	83.60M
Shares Out	58.49M
EPS (ttm)	1.42
PE Ratio	9.80
Forward PE	5.30
Dividend	$0.60 (4.31%)
Ex-Dividend Date	Aug 29, 2025

Volume	1,206,628
Open	13.44
Previous Close	13.32
Day's Range	13.21 - 14.22
52-Week Range	9.20 - 21.48
Beta	1.04
Analysts	Buy
Price Target	19.00 (+36.4%)
Earnings Date	Aug 8, 2025

About EMBC

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1924
• Employees: 2,100
• Stock Exchange: NASDAQ
• Ticker Symbol: EMBC
• Website: https://www.embecta.com

Financial Performance

In 2024, Embecta's revenue was $1.12 billion, an increase of 0.21% compared to the previous year's $1.12 billion. Earnings were $78.30 million, an increase of 11.22%.

Analyst Forecast

According to 2 analysts, the average rating for EMBC stock is "Buy." The 12-month stock price target is $19.0, which is an increase of 36.40% from the latest price.

Price Target

$19.0

(36.40% upside)

Analyst Consensus: Buy